BeiGene and Singlomics sign license agreement for neutralizing COVID-19 antibodies identifed with scRNA-Seq

August 31, 2020 Leave a comment 2,330 Views

BeiGene, Ltd. and Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., today announced that the companies have executed an exclusive license agreement for BeiGene to develop, manufacture and...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Singlomics Biopharmaceuticals

BeiGene and Singlomics sign license agreement for neutralizing COVID-19 antibodies identifed with scRNA-Seq

DREEP – predicting drug response from single-cell expression profiles of tumours

Researchers discover new classes of RNA for learning and memory

TECprobe-VL – variable length transcription elongation complex RNA structure probing

Long-read scRNA-seq to become increasingly relevant in oncology and personalized medicine

Quest Diagnostics and Scipher Medicine collaborate to scale precision medicine access for patients with rheumatoid arthritis

Voltage-Seq – all-optical voltage imaging-guided postsynaptic single-cell transcriptome profiling

Researchers identify three genes associated with neurodevelopmental disorders